Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.

Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

Daiichi Sankyo licenses two abuse-deterrent painkillers from Inspirion to further its pain-management ambitions.

China's FDA says reports that 83% of trials have fabricated results are incorrect, but the numbers suggest the country still has a big data-integrity…

Daiichi Sankyo's ambition to build a pipeline of new oncology drugs may have just taken another big hit.

Biosimilar developers are queueing up to file copycat versions of AbbVie's Humira, the world's best-selling drug, and now, another candidate has late…